Ekso Bionics Holdings, Inc. designs, develops, and markets exoskeleton products. Its exoskeleton technology serves multiple markets and can be utilized both by able-bodied persons and persons with physical disabilities or impairments. Its products include EksoNR, which is a wearable robotic exoskeleton specifically designed to be used in a rehabilitation setting; Ekso Indego Therapy is a modular, adjustable, lightweight, lower-limb powered exoskeleton; Ekso Indego Personal is a lightweight powered lower limb orthosis; Ekso Nomad is a power Knee Ankle Foot Orthosis, and Ekso EVO is a wearable upper body exoskeleton. The Company enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate and to walk again; assist individuals with a range of upper extremity impairments and allow industrial workers to perform difficult repetitive work for extended periods. Its segments include EksoHealth and EksoWorks.
企業コードEKSO
会社名Ekso Bionics Holdings Inc
上場日Apr 10, 2013
最高経営責任者「CEO」Mr. Scott G. Davis
従業員数61
証券種類Ordinary Share
決算期末Apr 10
本社所在地101 Glacier Point
都市SAN RAFAEL
証券取引所NASDAQ Capital Market Consolidated
国United States of America
郵便番号94901
電話番号15109841761
ウェブサイトhttps://eksobionics.com/
企業コードEKSO
上場日Apr 10, 2013
最高経営責任者「CEO」Mr. Scott G. Davis
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし